{"filing":{"accession_number":"0001493152-26-035743","cik":"0001412486","ticker":"COCP","company_name":"Cocrystal Pharma, Inc.","form":"8-K","filing_date":"2026-08-03","report_date":"2026-07-31","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226035743/form8-k.htm"},"events":[{"id":23409,"run_id":21162,"accession_number":"0001493152-26-035743","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses an unregistered private placement of 5,474,053 shares of common stock to OPKO Health at $0.9134 per share for $5.0 million gross proceeds, exempt under Section 4(a)(2) and Regulation D. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure, particularly given the significant share count increase and the involvement of a related party (Dr. Phillip Frost, who is co-founder and principal stockholder of Cocrystal).","company_name":"Cocrystal Pharma, Inc.","ticker":"COCP","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":23626,"accession_number":"0001493152-26-035743","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses an unregistered private placement of 5,474,053 shares of common stock to OPKO Health at $0.9134 per share for $5.0 million gross proceeds, exempt under Section 4(a)(2) and Regulation D. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure, particularly given the significant share count increase and the involvement of a related party (Dr. Phillip Frost, who is co-founder and principal stockholder of Cocrystal).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:26:31.815930+00:00","company_name":"Cocrystal Pharma, Inc.","ticker":"COCP","filing_date":"2026-08-03"}]}